イルミメディカル株式会社は、シリーズA資金調達ラウンドを完了し、総額5.5億円を調達しました。このラウンドは、2025年10月から2025年初頭にかけて、複数の段階に分けて行われました。
Cellid Inc., a developer of displays and spatial recognition engines for next-generation…
Neusignal Therapeutics Inc., a Tohoku University-based company developing treatments for Alzheimer's disease,…
Panasonic Holdings Corporation has become the first company in Japan to obtain…
We are pleased to announce that our overseas subsidiary, YAMABIKO EUROPE S.A.,…
AGEST Inc., a company that supports the improvement of software quality and…
Zaimo Inc. is pleased to announce that it has raised approximately 100…
Colega AI Inc., which provides the AI editing service "Colega AI" that…
The Quantum Forum Quantum Computer Technology Promotion Committee (Inc.) will be holding…
Cellid Inc., a developer of displays and spatial recognition engines for next-generation…
Neusignal Therapeutics Inc., a Tohoku University-based company developing treatments for Alzheimer's disease,…
Panasonic Holdings Corporation has become the first company in Japan to obtain…
We are pleased to announce that our overseas subsidiary, YAMABIKO EUROPE S.A.,…
AGEST Inc., a company that supports the improvement of software quality and…
Zaimo Inc. is pleased to announce that it has raised approximately 100…
Colega AI Inc., which provides the AI editing service "Colega AI" that…
The Quantum Forum Quantum Computer Technology Promotion Committee (Inc.) will be holding…
アカウントにサインインする